Featured Speakers

• 

  Weichang ZhouSenior Director, Commercial Cell Culture Development Genzyme

• 

  David PollardAssociate Director, Bioprocess R&D Merck & Co

• 

  Tina LarsonSenior Director, Process Development Operations & Engineering Genentech

• 

  Gene LeeDirector, Cell & Protein Sciences EMD Serono

Overcome process complexity and deliver maximum yield from your manufacturing process

The constant drive to streamline processes and improve yield underpins all manufacturing.  Whether you’re working on mAbs, ADCs, bispecifics or other formats you’ll know that getting your process right is key to demonstrating commercial viability. Process complexity is driving up costs and raising the challenge of how to increase manufacturing yield and efficiency.

Next Generation Antibody Manufacturing will address the latest developments in mAb processing and tackle the new manufacturing challenges you are facing with your innovative products.  This meeting will help you maximize antibody titers, adapt and improve your product recovery methods and streamline process development.   With expert talks from Genentech, Millennium, Genzyme, Abbott and many more this is your best opportunity to get up to speed with the cutting edge technologies, processes and maximize your yield.

Top sessions not to be missed:

• Genentech describe how they are aligning people, technology and work processes to achieve reliable next generation antibody manufacturing operations
• Genzyme and Merck will reveal their tools for using continuous processing to minimize production down time
• Insights into the challenges in bispecific antibody expression and purification with F-star, NovImmune and Macrogenics
• See how Merrimack are assaying bispecific metabolites produced during CHO expression processes
• Progenics will explain how they are tackling the challenge of conducting robust stability monitoring and routine lot-release testing for their ADC and, Millennium and Abbott will describe their perspectives on ADC CMC CQAs
• Imclone’s highlight how their CMC project management team has dramatically improved overall manufacturing efficiency
• Hear Roche and EMD Serono discuss the optimal approaches to cell line development for mAbs and engineered antibodies

For more information on what will be covered in the meeting, please download the draft agenda now. To book your place, simply register online or get in touch by emailing :  info@hansonwade.com or calling +1 212 537 5898. 

If you have any questions, please don’t hesitate to contact us.